Advertisement

Sun Pharma Managing Director News

alt
Sun Pharma may discontinue certain non-strategic businesses as part of its integration process with Ranbaxy Laboratories, which it acquired in a USD 4 billion deal last year.






Loading...
english news
NEWS ON ONE CLICK